Sunil Gairola
0000-0003-4093-9736
1 paper found
Refreshing results…
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
Missing publications? Search for publications with a matching author name.